New £30m initiative launched to support innovation against antimicrobial resistance
Global innovators can apply to PACE to receive up to £1m per project
Read More
Tag: Medicines Discovery Catapult
UK launches its first national PET imaging platform for drug discovery
NPIP will transform medical research and provide better outcomes for patients
Read More
New joint venture aims to ‘open’ funding opportunities for early medicines discovery
Collaboration will drive medicines discovery in areas of unmet patient need
Read More
Psychiatry Consortium funds project investigating new schizophrenia treatments
Project will see the University of Oxford partner with the Earlham Institute, Biogen and Boehringer Ingelheim
Read More
Uni of Exeter partners with MDC to accelerate academic medicines research
Medicines Discovery Catapult (MDC) will offer industry skills and discovery platforms
Read More
Oncimmune/Medicines Discovery Catapult win UK government funding for COVID-19 research tool
Research tool will predict disease severity and therapeutic response
Read More
New partnership to explore cellular aspect of COVID-19 infection
The groups hope to discover cellular receptors or binding proteins of COVID-19
Read More
Medicines Discovery Catapult, MQ, Alzheimer’s Research UK form alliance
The partnership will focus on identifying and validating novel drug targets for unmet therapeutic needs for psychiatric symptoms affecting people with mental health conditions
Read More
UK should be “proud” of service and supply sector
Service and supply companies account for 80% of small and medium enterprises (SMEs) in UK medicines discovery, and 90% of employment.
Read More
New alliance strives to advance human-based drug evaluation
Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the University of Liverpool have announced plans to work together on the development of next generation human cell models to advance human based drug discovery.
Read More
AI drug discovery platform gets £1m innovation boost
Innovate UK is streaming funds into a £1-million artificial intelligence (AI) research project to be delivered by the Medicines Discovery Catapult and two Cambridge-based firms with expertise in software/machine learning.
Read More
Groups hails potential of organ on a chip tech for UK
The Medicines Discovery Catapult, the Centre for Drug Safety Sciences at the University of Liverpool and the National Centre for the Replacement Refinement & Reduction of Animals in Research are working together to “propel” the UK into the race to advance organ on a chip technology.
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
